• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用机器学习工具,通过等离子体光栅生物传感器对临床结核分枝杆菌样本中的脂阿拉伯甘露聚糖进行超灵敏检测。

Applications of machine learning tools for ultra-sensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of tuberculosis.

机构信息

Department of Statistics, University of Missouri, Columbia, Missouri, United States of America.

Department of Electrical Engineering & Computer Science, Center for Nano/Micro Systems & Nanotechnology, University of Missouri, Columbia, Missouri, United States of America.

出版信息

PLoS One. 2022 Oct 25;17(10):e0275658. doi: 10.1371/journal.pone.0275658. eCollection 2022.

DOI:10.1371/journal.pone.0275658
PMID:36282804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9595565/
Abstract

BACKGROUND

Tuberculosis is one of the top ten causes of death globally and the leading cause of death from a single infectious agent. Eradicating the Tuberculosis epidemic by 2030 is one of the top United Nations Sustainable Development Goals. Early diagnosis is essential to achieving this goal because it improves individual prognosis and reduces transmission rates of asymptomatic infected. We aim to support this goal by developing rapid and sensitive diagnostics using machine learning algorithms to minimize the need for expert intervention.

METHODS AND FINDINGS

A single molecule fluorescence immunosorbent assay was used to detect Tuberculosis biomarker lipoarabinomannan from a set of twenty clinical patient samples and a control set of spiked human urine. Tuberculosis status was separately confirmed by GeneXpert MTB/RIF and cell culture. Two machine learning algorithms, an automatic and a semiautomatic model, were developed and trained by the calibrated lipoarabinomannan titration assay data and then tested against the ground truth patient data. The semiautomatic model differed from the automatic model by an expert review step in the former, which calibrated the lower threshold to determine single molecules from background noise. The semiautomatic model was found to provide 88.89% clinical sensitivity, while the automatic model resulted in 77.78% clinical sensitivity.

CONCLUSIONS

The semiautomatic model outperformed the automatic model in clinical sensitivity as a result of the expert intervention applied during calibration and both models vastly outperformed manual expert counting in terms of time-to-detection and completion of analysis. Meanwhile, the clinical sensitivity of the automatic model could be improved significantly with a larger training dataset. In short, semiautomatic, and automatic Gaussian Mixture Models have a place in supporting rapid detection of Tuberculosis in resource-limited settings without sacrificing clinical sensitivity.

摘要

背景

结核病是全球十大死因之一,也是单一传染病病原体导致的主要死因。到 2030 年消除结核病流行是联合国可持续发展目标之一。早期诊断对于实现这一目标至关重要,因为它可以改善个体预后并降低无症状感染者的传播率。我们旨在通过使用机器学习算法开发快速而敏感的诊断方法来支持这一目标,从而最大限度地减少对专家干预的需求。

方法和发现

我们使用单分子荧光免疫吸附测定法从 20 例临床患者样本和一组人工添加的人尿对照样本中检测结核病生物标志物脂阿拉伯甘露聚糖。结核病状态分别通过 GeneXpert MTB/RIF 和细胞培养来确认。我们开发了两种机器学习算法,一种是自动模型,另一种是半自动模型,它们通过经过校准的脂阿拉伯甘露聚糖滴定测定数据进行训练,然后对真实患者数据进行测试。半自动模型与自动模型的不同之处在于前者有一个专家审查步骤,该步骤校准了较低的阈值,以确定来自背景噪声的单个分子。结果发现,半自动模型的临床灵敏度为 88.89%,而自动模型的临床灵敏度为 77.78%。

结论

半自动模型通过在校准过程中应用专家干预,在临床灵敏度方面优于自动模型,而这两种模型在检测时间和分析完成时间方面都大大优于手动专家计数。同时,通过使用更大的训练数据集,自动模型的临床灵敏度可以得到显著提高。总之,半自动和自动高斯混合模型在不牺牲临床灵敏度的情况下,在资源有限的环境中支持快速检测结核病具有一定的地位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/9a91fcdfaf7e/pone.0275658.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/1f0509c0362d/pone.0275658.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/b69c8bf1009d/pone.0275658.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/481fb980d4bc/pone.0275658.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/64a40c46fd28/pone.0275658.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/d5e13c9464d9/pone.0275658.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/9a91fcdfaf7e/pone.0275658.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/1f0509c0362d/pone.0275658.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/b69c8bf1009d/pone.0275658.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/481fb980d4bc/pone.0275658.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/64a40c46fd28/pone.0275658.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/d5e13c9464d9/pone.0275658.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa7/9595565/9a91fcdfaf7e/pone.0275658.g006.jpg

相似文献

1
Applications of machine learning tools for ultra-sensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of tuberculosis.应用机器学习工具,通过等离子体光栅生物传感器对临床结核分枝杆菌样本中的脂阿拉伯甘露聚糖进行超灵敏检测。
PLoS One. 2022 Oct 25;17(10):e0275658. doi: 10.1371/journal.pone.0275658. eCollection 2022.
2
The New Xpert MTB/RIF Ultra: Improving Detection of and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.新型Xpert MTB/RIF Ultra:在适用于即时检测的检测方法中提高对结核分枝杆菌的检测及利福平耐药性检测
mBio. 2017 Aug 29;8(4):e00812-17. doi: 10.1128/mBio.00812-17.
3
Ultrasensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis.超敏检测脂阿拉伯甘露聚糖与等离子体光栅生物传感器在临床样本中的 HIV 阴性结核病患者。
PLoS One. 2019 Mar 26;14(3):e0214161. doi: 10.1371/journal.pone.0214161. eCollection 2019.
4
Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience.在痰液以外的肺外和呼吸道样本上评估GeneXpert MTB/RIF检测:一个低负担国家的经验
Pathology. 2017 Jan;49(1):70-74. doi: 10.1016/j.pathol.2016.10.004. Epub 2016 Nov 29.
5
Evaluation of the GeneXpert MTB/RIF assay performance in sputum samples with various characteristics from presumed pulmonary tuberculosis patients in Shiselweni region, Eswatini.在斯威士兰希塞尔韦尼地区疑似肺结核患者具有不同特征的痰液样本中对GeneXpert MTB/RIF检测性能的评估。
Infect Dis (Lond). 2022 Mar;54(3):170-177. doi: 10.1080/23744235.2021.1992005. Epub 2021 Oct 27.
6
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
7
[Application of Gene Xpert Mycobacterium tuberculosis DNA and resistance to rifampicin assay in the rapid detection of tuberculosis in children].[基因Xpert结核分枝杆菌DNA及利福平耐药检测在儿童结核病快速诊断中的应用]
Zhonghua Er Ke Za Zhi. 2016 May;54(5):370-4. doi: 10.3760/cma.j.issn.0578-1310.2016.05.012.
8
Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens.GeneXpert MTB/RIF assay 用于快速诊断肺结核和检测肺部及肺外标本中利福平耐药性的评价。
J Clin Microbiol. 2011 Dec;49(12):4138-41. doi: 10.1128/JCM.05434-11. Epub 2011 Sep 28.
9
GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance detection of endobronchial tuberculosis.GeneXpert MTB/RIF 快速诊断和利福平耐药检测在支气管内结核中的应用。
Respirology. 2018 Oct;23(10):950-955. doi: 10.1111/resp.13316. Epub 2018 Apr 24.
10
Evaluation of GeneXpert /Rifampin for the detection of complex and rifampicin resistance in nonrespiratory clinical specimens.使用GeneXpert/利福平检测非呼吸道临床标本中的复合耐药和利福平耐药情况评估
Int J Mycobacteriol. 2019 Apr-Jun;8(2):132-137. doi: 10.4103/ijmy.ijmy_83_19.

引用本文的文献

1
Diagnostic Performance of Artificial Intelligence-Based Methods for Tuberculosis Detection: Systematic Review.基于人工智能的结核病检测方法的诊断性能:系统评价
J Med Internet Res. 2025 Mar 7;27:e69068. doi: 10.2196/69068.
2
Urine lipoarabinomannan concentrations among HIV-negative adults with pulmonary or extrapulmonary tuberculosis disease in Vietnam.越南肺结核病(肺内或肺外)的HIV阴性成人尿液中脂阿拉伯甘露聚糖的浓度
PLOS Glob Public Health. 2024 Nov 6;4(11):e0003891. doi: 10.1371/journal.pgph.0003891. eCollection 2024.
3
Hybrid Polystyrene-Plasmonic Systems as High Binding Density Biosensing Platforms.

本文引用的文献

1
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis.2019年冠状病毒病大流行对结核病流行的潜在影响:一项建模分析
EClinicalMedicine. 2020 Oct 24;28:100603. doi: 10.1016/j.eclinm.2020.100603. eCollection 2020 Nov.
2
Tuberculosis in the era of COVID-19 in India.印度新冠疫情时代的结核病
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1439-1443. doi: 10.1016/j.dsx.2020.07.034. Epub 2020 Jul 29.
3
On tuberculosis and COVID-19 co-infection.关于结核病和 COVID-19 合并感染。
杂化聚苯乙烯-等离子体系统作为高结合密度生物传感平台。
Int J Mol Sci. 2024 Aug 7;25(16):8603. doi: 10.3390/ijms25168603.
Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.02328-2020. Print 2020 Aug.
4
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.活动性肺结核、后遗症与 COVID-19 合并感染:49 例首批队列。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
5
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts.结核病、COVID-19 和移民:对两个队列中 69 例死亡患者的初步分析。
Pulmonology. 2020 Jul-Aug;26(4):233-240. doi: 10.1016/j.pulmoe.2020.05.002. Epub 2020 May 14.
6
Tuberculosis and HIV responses threatened by COVID-19.结核病和艾滋病应对措施受到新冠疫情的威胁。
Lancet HIV. 2020 May;7(5):e319-e320. doi: 10.1016/S2352-3018(20)30109-0. Epub 2020 Apr 8.
7
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.评估 SARS-CoV-2 在临床标本中的 RNA 释放情况,以及澳门 10 例 COVID-19 患者的临床特征。
Int J Biol Sci. 2020 Mar 15;16(10):1698-1707. doi: 10.7150/ijbs.45357. eCollection 2020.
8
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
9
A case of coronavirus disease 2019 with twice negative nucleic acid testing within 8 days.1例新型冠状病毒肺炎患者8天内核酸检测两次呈阴性。
Chin Med J (Engl). 2020 Jun 20;133(12):1487-1488. doi: 10.1097/CM9.0000000000000788.
10
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.